Nestlé quarterly financial reports or credible market analysis reports

Nestlé Launches $5 'Vital Pursuit' Frozen Food Line for GLP-1 Drug Users in October

May 21, 2024, 04:30 PM

Nestlé is launching a new frozen food brand called 'Vital Pursuit,' specifically designed for users of GLP-1 weight-loss medications such as Ozempic, Wegovy, and Mounjaro. The product line, which includes $5 frozen pizzas, sandwiches, and protein-enriched pastas, aims to cater to the growing market of consumers using these popular drugs. The new brand is set to hit U.S. shelves in October and is formulated to support a balanced diet with more protein, iron, calcium, and high-fiber content. Additionally, the products are portion-aligned to support weight management. Nestlé's initiative targets a market expected to reach $30 billion in the next six years.